Baidu
map
FRONT SURG 润色咨询

Frontiers in Surgery

出版年份：暂无数据 年文章数：1761 投稿命中率： 开通期刊会员，数据随心看

出版周期：C 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1211916, encodeId=4954121191603, content=Enter your thread title<br>这是要填什么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Apr 17 15:16:07 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135109, encodeId=cfe72135109f5, content=偏重的研究方向：外科<br>经验分享：final validation阶段需要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f62574267, createdName=1258d7a0m09暂无昵称, createdTime=Tue May 16 13:58:54 CST 2023, time=2023-05-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116508, encodeId=2e562116508af, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：2022.10.11投稿 2022.11月底接受 版面费交了 proof也提交了。2023.1月底说我文章外审有问题，重新拒绝退回版面费。非常差的一次体验。后来预警期刊出来了被预警了，以后不会考虑这个系列了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/25/b822cea76f86c21288adfae363c6acee.jpg, createdBy=b6602342517, createdName=YYS9508, createdTime=Sun Feb 26 09:58:21 CST 2023, time=2023-02-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2094855, encodeId=4c9b2094855e3, content=投了一篇case，两个审稿人打分都挺高，直接让小修后发表，在编辑那里等了半个月后直接拒稿，说不符合发表要求，请问这是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210429/0b370c04c4bc468c8fc0295b10899aec/93fd51e1588243e988a6774ce1b01133.jpg, createdBy=5dd75468579, createdName=杨豆豆哎, createdTime=Wed Oct 19 23:40:04 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112666, encodeId=f0dc2112666e3, content=偏重的研究方向：外科手术<br>经验分享：我版面费没交，文章也发表了，是什么情况，今年还进了预警名单，在考虑要不要撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ce16588031, createdName=ms3000000392481740, createdTime=Wed Feb 01 23:52:02 CST 2023, time=2023-02-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2112308, encodeId=5b5521123087c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：外科<br>经验分享：被预警了啊！！！ https://earlywarning.fenqubiao.com/#/zh-cn/early-warning-journal-list-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Jan 31 01:44:15 CST 2023, time=2023-01-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1237965, encodeId=fca9123e96570, content=偏重的研究方向：胃癌<br>经验分享：很开心，今天刚收到invoive,同意发表，经历了大概5个月，给了一次小修，感觉难度不大，本人做的是本院临床数据库的nomo模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Thu Aug 11 00:37:07 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237840, encodeId=1fdc123e8404f, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿太慢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17db5680759, createdName=ms8000000287670154, createdTime=Wed Aug 10 14:55:45 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102855, encodeId=a67c21028556b, content=你们一般proof后多久见刊的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Sun Nov 27 09:43:37 CST 2022, time=2022-11-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248539, encodeId=2df71248539b7, content=2个审稿人都接收了，4天过去编辑还没给消息。。什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Sep 12 20:23:46 CST 2022, time=2022-09-12, status=1, ipAttribution=)]
    2022-04-17 ms1000000108142926

    Enter your thread title
    这是要填什么？

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1211916, encodeId=4954121191603, content=Enter your thread title<br>这是要填什么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Apr 17 15:16:07 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135109, encodeId=cfe72135109f5, content=偏重的研究方向：外科<br>经验分享：final validation阶段需要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f62574267, createdName=1258d7a0m09暂无昵称, createdTime=Tue May 16 13:58:54 CST 2023, time=2023-05-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116508, encodeId=2e562116508af, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：2022.10.11投稿 2022.11月底接受 版面费交了 proof也提交了。2023.1月底说我文章外审有问题，重新拒绝退回版面费。非常差的一次体验。后来预警期刊出来了被预警了，以后不会考虑这个系列了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/25/b822cea76f86c21288adfae363c6acee.jpg, createdBy=b6602342517, createdName=YYS9508, createdTime=Sun Feb 26 09:58:21 CST 2023, time=2023-02-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2094855, encodeId=4c9b2094855e3, content=投了一篇case，两个审稿人打分都挺高，直接让小修后发表，在编辑那里等了半个月后直接拒稿，说不符合发表要求，请问这是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210429/0b370c04c4bc468c8fc0295b10899aec/93fd51e1588243e988a6774ce1b01133.jpg, createdBy=5dd75468579, createdName=杨豆豆哎, createdTime=Wed Oct 19 23:40:04 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112666, encodeId=f0dc2112666e3, content=偏重的研究方向：外科手术<br>经验分享：我版面费没交，文章也发表了，是什么情况，今年还进了预警名单，在考虑要不要撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ce16588031, createdName=ms3000000392481740, createdTime=Wed Feb 01 23:52:02 CST 2023, time=2023-02-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2112308, encodeId=5b5521123087c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：外科<br>经验分享：被预警了啊！！！ https://earlywarning.fenqubiao.com/#/zh-cn/early-warning-journal-list-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Jan 31 01:44:15 CST 2023, time=2023-01-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1237965, encodeId=fca9123e96570, content=偏重的研究方向：胃癌<br>经验分享：很开心，今天刚收到invoive,同意发表，经历了大概5个月，给了一次小修，感觉难度不大，本人做的是本院临床数据库的nomo模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Thu Aug 11 00:37:07 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237840, encodeId=1fdc123e8404f, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿太慢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17db5680759, createdName=ms8000000287670154, createdTime=Wed Aug 10 14:55:45 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102855, encodeId=a67c21028556b, content=你们一般proof后多久见刊的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Sun Nov 27 09:43:37 CST 2022, time=2022-11-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248539, encodeId=2df71248539b7, content=2个审稿人都接收了，4天过去编辑还没给消息。。什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Sep 12 20:23:46 CST 2022, time=2022-09-12, status=1, ipAttribution=)]
    2023-05-16 1258d7a0m09暂无昵称 来自山东省

    偏重的研究方向：外科
    经验分享：final validation阶段需要等多久？

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1211916, encodeId=4954121191603, content=Enter your thread title<br>这是要填什么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Apr 17 15:16:07 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135109, encodeId=cfe72135109f5, content=偏重的研究方向：外科<br>经验分享：final validation阶段需要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f62574267, createdName=1258d7a0m09暂无昵称, createdTime=Tue May 16 13:58:54 CST 2023, time=2023-05-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116508, encodeId=2e562116508af, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：2022.10.11投稿 2022.11月底接受 版面费交了 proof也提交了。2023.1月底说我文章外审有问题，重新拒绝退回版面费。非常差的一次体验。后来预警期刊出来了被预警了，以后不会考虑这个系列了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/25/b822cea76f86c21288adfae363c6acee.jpg, createdBy=b6602342517, createdName=YYS9508, createdTime=Sun Feb 26 09:58:21 CST 2023, time=2023-02-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2094855, encodeId=4c9b2094855e3, content=投了一篇case，两个审稿人打分都挺高，直接让小修后发表，在编辑那里等了半个月后直接拒稿，说不符合发表要求，请问这是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210429/0b370c04c4bc468c8fc0295b10899aec/93fd51e1588243e988a6774ce1b01133.jpg, createdBy=5dd75468579, createdName=杨豆豆哎, createdTime=Wed Oct 19 23:40:04 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112666, encodeId=f0dc2112666e3, content=偏重的研究方向：外科手术<br>经验分享：我版面费没交，文章也发表了，是什么情况，今年还进了预警名单，在考虑要不要撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ce16588031, createdName=ms3000000392481740, createdTime=Wed Feb 01 23:52:02 CST 2023, time=2023-02-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2112308, encodeId=5b5521123087c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：外科<br>经验分享：被预警了啊！！！ https://earlywarning.fenqubiao.com/#/zh-cn/early-warning-journal-list-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Jan 31 01:44:15 CST 2023, time=2023-01-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1237965, encodeId=fca9123e96570, content=偏重的研究方向：胃癌<br>经验分享：很开心，今天刚收到invoive,同意发表，经历了大概5个月，给了一次小修，感觉难度不大，本人做的是本院临床数据库的nomo模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Thu Aug 11 00:37:07 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237840, encodeId=1fdc123e8404f, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿太慢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17db5680759, createdName=ms8000000287670154, createdTime=Wed Aug 10 14:55:45 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102855, encodeId=a67c21028556b, content=你们一般proof后多久见刊的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Sun Nov 27 09:43:37 CST 2022, time=2022-11-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248539, encodeId=2df71248539b7, content=2个审稿人都接收了，4天过去编辑还没给消息。。什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Sep 12 20:23:46 CST 2022, time=2022-09-12, status=1, ipAttribution=)]
    2023-02-26 YYS9508 来自上海

    审稿速度:2.0 | 投稿命中率:95.0
    经验分享：2022.10.11投稿 2022.11月底接受 版面费交了 proof也提交了。2023.1月底说我文章外审有问题，重新拒绝退回版面费。非常差的一次体验。后来预警期刊出来了被预警了，以后不会考虑这个系列了。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1211916, encodeId=4954121191603, content=Enter your thread title<br>这是要填什么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Apr 17 15:16:07 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135109, encodeId=cfe72135109f5, content=偏重的研究方向：外科<br>经验分享：final validation阶段需要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f62574267, createdName=1258d7a0m09暂无昵称, createdTime=Tue May 16 13:58:54 CST 2023, time=2023-05-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116508, encodeId=2e562116508af, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：2022.10.11投稿 2022.11月底接受 版面费交了 proof也提交了。2023.1月底说我文章外审有问题，重新拒绝退回版面费。非常差的一次体验。后来预警期刊出来了被预警了，以后不会考虑这个系列了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/25/b822cea76f86c21288adfae363c6acee.jpg, createdBy=b6602342517, createdName=YYS9508, createdTime=Sun Feb 26 09:58:21 CST 2023, time=2023-02-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2094855, encodeId=4c9b2094855e3, content=投了一篇case，两个审稿人打分都挺高，直接让小修后发表，在编辑那里等了半个月后直接拒稿，说不符合发表要求，请问这是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210429/0b370c04c4bc468c8fc0295b10899aec/93fd51e1588243e988a6774ce1b01133.jpg, createdBy=5dd75468579, createdName=杨豆豆哎, createdTime=Wed Oct 19 23:40:04 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112666, encodeId=f0dc2112666e3, content=偏重的研究方向：外科手术<br>经验分享：我版面费没交，文章也发表了，是什么情况，今年还进了预警名单，在考虑要不要撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ce16588031, createdName=ms3000000392481740, createdTime=Wed Feb 01 23:52:02 CST 2023, time=2023-02-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2112308, encodeId=5b5521123087c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：外科<br>经验分享：被预警了啊！！！ https://earlywarning.fenqubiao.com/#/zh-cn/early-warning-journal-list-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Jan 31 01:44:15 CST 2023, time=2023-01-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1237965, encodeId=fca9123e96570, content=偏重的研究方向：胃癌<br>经验分享：很开心，今天刚收到invoive,同意发表，经历了大概5个月，给了一次小修，感觉难度不大，本人做的是本院临床数据库的nomo模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Thu Aug 11 00:37:07 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237840, encodeId=1fdc123e8404f, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿太慢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17db5680759, createdName=ms8000000287670154, createdTime=Wed Aug 10 14:55:45 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102855, encodeId=a67c21028556b, content=你们一般proof后多久见刊的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Sun Nov 27 09:43:37 CST 2022, time=2022-11-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248539, encodeId=2df71248539b7, content=2个审稿人都接收了，4天过去编辑还没给消息。。什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Sep 12 20:23:46 CST 2022, time=2022-09-12, status=1, ipAttribution=)]
    2022-10-19 杨豆豆哎

    投了一篇case，两个审稿人打分都挺高，直接让小修后发表，在编辑那里等了半个月后直接拒稿，说不符合发表要求，请问这是什么意思啊

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1211916, encodeId=4954121191603, content=Enter your thread title<br>这是要填什么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Apr 17 15:16:07 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135109, encodeId=cfe72135109f5, content=偏重的研究方向：外科<br>经验分享：final validation阶段需要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f62574267, createdName=1258d7a0m09暂无昵称, createdTime=Tue May 16 13:58:54 CST 2023, time=2023-05-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116508, encodeId=2e562116508af, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：2022.10.11投稿 2022.11月底接受 版面费交了 proof也提交了。2023.1月底说我文章外审有问题，重新拒绝退回版面费。非常差的一次体验。后来预警期刊出来了被预警了，以后不会考虑这个系列了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/25/b822cea76f86c21288adfae363c6acee.jpg, createdBy=b6602342517, createdName=YYS9508, createdTime=Sun Feb 26 09:58:21 CST 2023, time=2023-02-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2094855, encodeId=4c9b2094855e3, content=投了一篇case，两个审稿人打分都挺高，直接让小修后发表，在编辑那里等了半个月后直接拒稿，说不符合发表要求，请问这是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210429/0b370c04c4bc468c8fc0295b10899aec/93fd51e1588243e988a6774ce1b01133.jpg, createdBy=5dd75468579, createdName=杨豆豆哎, createdTime=Wed Oct 19 23:40:04 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112666, encodeId=f0dc2112666e3, content=偏重的研究方向：外科手术<br>经验分享：我版面费没交，文章也发表了，是什么情况，今年还进了预警名单，在考虑要不要撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ce16588031, createdName=ms3000000392481740, createdTime=Wed Feb 01 23:52:02 CST 2023, time=2023-02-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2112308, encodeId=5b5521123087c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：外科<br>经验分享：被预警了啊！！！ https://earlywarning.fenqubiao.com/#/zh-cn/early-warning-journal-list-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Jan 31 01:44:15 CST 2023, time=2023-01-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1237965, encodeId=fca9123e96570, content=偏重的研究方向：胃癌<br>经验分享：很开心，今天刚收到invoive,同意发表，经历了大概5个月，给了一次小修，感觉难度不大，本人做的是本院临床数据库的nomo模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Thu Aug 11 00:37:07 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237840, encodeId=1fdc123e8404f, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿太慢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17db5680759, createdName=ms8000000287670154, createdTime=Wed Aug 10 14:55:45 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102855, encodeId=a67c21028556b, content=你们一般proof后多久见刊的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Sun Nov 27 09:43:37 CST 2022, time=2022-11-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248539, encodeId=2df71248539b7, content=2个审稿人都接收了，4天过去编辑还没给消息。。什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Sep 12 20:23:46 CST 2022, time=2022-09-12, status=1, ipAttribution=)]
    2023-02-01 ms3000000392481740 来自福建省

    偏重的研究方向：外科手术
    经验分享：我版面费没交，文章也发表了，是什么情况，今年还进了预警名单，在考虑要不要撤稿

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1211916, encodeId=4954121191603, content=Enter your thread title<br>这是要填什么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Apr 17 15:16:07 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135109, encodeId=cfe72135109f5, content=偏重的研究方向：外科<br>经验分享：final validation阶段需要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f62574267, createdName=1258d7a0m09暂无昵称, createdTime=Tue May 16 13:58:54 CST 2023, time=2023-05-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116508, encodeId=2e562116508af, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：2022.10.11投稿 2022.11月底接受 版面费交了 proof也提交了。2023.1月底说我文章外审有问题，重新拒绝退回版面费。非常差的一次体验。后来预警期刊出来了被预警了，以后不会考虑这个系列了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/25/b822cea76f86c21288adfae363c6acee.jpg, createdBy=b6602342517, createdName=YYS9508, createdTime=Sun Feb 26 09:58:21 CST 2023, time=2023-02-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2094855, encodeId=4c9b2094855e3, content=投了一篇case，两个审稿人打分都挺高，直接让小修后发表，在编辑那里等了半个月后直接拒稿，说不符合发表要求，请问这是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210429/0b370c04c4bc468c8fc0295b10899aec/93fd51e1588243e988a6774ce1b01133.jpg, createdBy=5dd75468579, createdName=杨豆豆哎, createdTime=Wed Oct 19 23:40:04 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112666, encodeId=f0dc2112666e3, content=偏重的研究方向：外科手术<br>经验分享：我版面费没交，文章也发表了，是什么情况，今年还进了预警名单，在考虑要不要撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ce16588031, createdName=ms3000000392481740, createdTime=Wed Feb 01 23:52:02 CST 2023, time=2023-02-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2112308, encodeId=5b5521123087c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：外科<br>经验分享：被预警了啊！！！ https://earlywarning.fenqubiao.com/#/zh-cn/early-warning-journal-list-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Jan 31 01:44:15 CST 2023, time=2023-01-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1237965, encodeId=fca9123e96570, content=偏重的研究方向：胃癌<br>经验分享：很开心，今天刚收到invoive,同意发表，经历了大概5个月，给了一次小修，感觉难度不大，本人做的是本院临床数据库的nomo模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Thu Aug 11 00:37:07 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237840, encodeId=1fdc123e8404f, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿太慢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17db5680759, createdName=ms8000000287670154, createdTime=Wed Aug 10 14:55:45 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102855, encodeId=a67c21028556b, content=你们一般proof后多久见刊的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Sun Nov 27 09:43:37 CST 2022, time=2022-11-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248539, encodeId=2df71248539b7, content=2个审稿人都接收了，4天过去编辑还没给消息。。什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Sep 12 20:23:46 CST 2022, time=2022-09-12, status=1, ipAttribution=)]
    2023-01-31 jaimewang 来自山西省

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向：外科
    经验分享：被预警了啊！！！ https://earlywarning.fenqubiao.com/#/zh-cn/early-warning-journal-list-2023

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1211916, encodeId=4954121191603, content=Enter your thread title<br>这是要填什么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Apr 17 15:16:07 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135109, encodeId=cfe72135109f5, content=偏重的研究方向：外科<br>经验分享：final validation阶段需要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f62574267, createdName=1258d7a0m09暂无昵称, createdTime=Tue May 16 13:58:54 CST 2023, time=2023-05-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116508, encodeId=2e562116508af, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：2022.10.11投稿 2022.11月底接受 版面费交了 proof也提交了。2023.1月底说我文章外审有问题，重新拒绝退回版面费。非常差的一次体验。后来预警期刊出来了被预警了，以后不会考虑这个系列了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/25/b822cea76f86c21288adfae363c6acee.jpg, createdBy=b6602342517, createdName=YYS9508, createdTime=Sun Feb 26 09:58:21 CST 2023, time=2023-02-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2094855, encodeId=4c9b2094855e3, content=投了一篇case，两个审稿人打分都挺高，直接让小修后发表，在编辑那里等了半个月后直接拒稿，说不符合发表要求，请问这是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210429/0b370c04c4bc468c8fc0295b10899aec/93fd51e1588243e988a6774ce1b01133.jpg, createdBy=5dd75468579, createdName=杨豆豆哎, createdTime=Wed Oct 19 23:40:04 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112666, encodeId=f0dc2112666e3, content=偏重的研究方向：外科手术<br>经验分享：我版面费没交，文章也发表了，是什么情况，今年还进了预警名单，在考虑要不要撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ce16588031, createdName=ms3000000392481740, createdTime=Wed Feb 01 23:52:02 CST 2023, time=2023-02-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2112308, encodeId=5b5521123087c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：外科<br>经验分享：被预警了啊！！！ https://earlywarning.fenqubiao.com/#/zh-cn/early-warning-journal-list-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Jan 31 01:44:15 CST 2023, time=2023-01-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1237965, encodeId=fca9123e96570, content=偏重的研究方向：胃癌<br>经验分享：很开心，今天刚收到invoive,同意发表，经历了大概5个月，给了一次小修，感觉难度不大，本人做的是本院临床数据库的nomo模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Thu Aug 11 00:37:07 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237840, encodeId=1fdc123e8404f, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿太慢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17db5680759, createdName=ms8000000287670154, createdTime=Wed Aug 10 14:55:45 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102855, encodeId=a67c21028556b, content=你们一般proof后多久见刊的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Sun Nov 27 09:43:37 CST 2022, time=2022-11-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248539, encodeId=2df71248539b7, content=2个审稿人都接收了，4天过去编辑还没给消息。。什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Sep 12 20:23:46 CST 2022, time=2022-09-12, status=1, ipAttribution=)]
    2022-08-11 shademei

    偏重的研究方向：胃癌
    经验分享：很开心，今天刚收到invoive,同意发表，经历了大概5个月，给了一次小修，感觉难度不大，本人做的是本院临床数据库的nomo模型

    14

    展开14条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1211916, encodeId=4954121191603, content=Enter your thread title<br>这是要填什么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Apr 17 15:16:07 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135109, encodeId=cfe72135109f5, content=偏重的研究方向：外科<br>经验分享：final validation阶段需要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f62574267, createdName=1258d7a0m09暂无昵称, createdTime=Tue May 16 13:58:54 CST 2023, time=2023-05-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116508, encodeId=2e562116508af, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：2022.10.11投稿 2022.11月底接受 版面费交了 proof也提交了。2023.1月底说我文章外审有问题，重新拒绝退回版面费。非常差的一次体验。后来预警期刊出来了被预警了，以后不会考虑这个系列了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/25/b822cea76f86c21288adfae363c6acee.jpg, createdBy=b6602342517, createdName=YYS9508, createdTime=Sun Feb 26 09:58:21 CST 2023, time=2023-02-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2094855, encodeId=4c9b2094855e3, content=投了一篇case，两个审稿人打分都挺高，直接让小修后发表，在编辑那里等了半个月后直接拒稿，说不符合发表要求，请问这是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210429/0b370c04c4bc468c8fc0295b10899aec/93fd51e1588243e988a6774ce1b01133.jpg, createdBy=5dd75468579, createdName=杨豆豆哎, createdTime=Wed Oct 19 23:40:04 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112666, encodeId=f0dc2112666e3, content=偏重的研究方向：外科手术<br>经验分享：我版面费没交，文章也发表了，是什么情况，今年还进了预警名单，在考虑要不要撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ce16588031, createdName=ms3000000392481740, createdTime=Wed Feb 01 23:52:02 CST 2023, time=2023-02-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2112308, encodeId=5b5521123087c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：外科<br>经验分享：被预警了啊！！！ https://earlywarning.fenqubiao.com/#/zh-cn/early-warning-journal-list-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Jan 31 01:44:15 CST 2023, time=2023-01-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1237965, encodeId=fca9123e96570, content=偏重的研究方向：胃癌<br>经验分享：很开心，今天刚收到invoive,同意发表，经历了大概5个月，给了一次小修，感觉难度不大，本人做的是本院临床数据库的nomo模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Thu Aug 11 00:37:07 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237840, encodeId=1fdc123e8404f, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿太慢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17db5680759, createdName=ms8000000287670154, createdTime=Wed Aug 10 14:55:45 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102855, encodeId=a67c21028556b, content=你们一般proof后多久见刊的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Sun Nov 27 09:43:37 CST 2022, time=2022-11-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248539, encodeId=2df71248539b7, content=2个审稿人都接收了，4天过去编辑还没给消息。。什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Sep 12 20:23:46 CST 2022, time=2022-09-12, status=1, ipAttribution=)]
    2022-08-10 ms8000000287670154

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享：审稿太慢

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1211916, encodeId=4954121191603, content=Enter your thread title<br>这是要填什么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Apr 17 15:16:07 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135109, encodeId=cfe72135109f5, content=偏重的研究方向：外科<br>经验分享：final validation阶段需要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f62574267, createdName=1258d7a0m09暂无昵称, createdTime=Tue May 16 13:58:54 CST 2023, time=2023-05-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116508, encodeId=2e562116508af, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：2022.10.11投稿 2022.11月底接受 版面费交了 proof也提交了。2023.1月底说我文章外审有问题，重新拒绝退回版面费。非常差的一次体验。后来预警期刊出来了被预警了，以后不会考虑这个系列了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/25/b822cea76f86c21288adfae363c6acee.jpg, createdBy=b6602342517, createdName=YYS9508, createdTime=Sun Feb 26 09:58:21 CST 2023, time=2023-02-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2094855, encodeId=4c9b2094855e3, content=投了一篇case，两个审稿人打分都挺高，直接让小修后发表，在编辑那里等了半个月后直接拒稿，说不符合发表要求，请问这是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210429/0b370c04c4bc468c8fc0295b10899aec/93fd51e1588243e988a6774ce1b01133.jpg, createdBy=5dd75468579, createdName=杨豆豆哎, createdTime=Wed Oct 19 23:40:04 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112666, encodeId=f0dc2112666e3, content=偏重的研究方向：外科手术<br>经验分享：我版面费没交，文章也发表了，是什么情况，今年还进了预警名单，在考虑要不要撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ce16588031, createdName=ms3000000392481740, createdTime=Wed Feb 01 23:52:02 CST 2023, time=2023-02-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2112308, encodeId=5b5521123087c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：外科<br>经验分享：被预警了啊！！！ https://earlywarning.fenqubiao.com/#/zh-cn/early-warning-journal-list-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Jan 31 01:44:15 CST 2023, time=2023-01-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1237965, encodeId=fca9123e96570, content=偏重的研究方向：胃癌<br>经验分享：很开心，今天刚收到invoive,同意发表，经历了大概5个月，给了一次小修，感觉难度不大，本人做的是本院临床数据库的nomo模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Thu Aug 11 00:37:07 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237840, encodeId=1fdc123e8404f, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿太慢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17db5680759, createdName=ms8000000287670154, createdTime=Wed Aug 10 14:55:45 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102855, encodeId=a67c21028556b, content=你们一般proof后多久见刊的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Sun Nov 27 09:43:37 CST 2022, time=2022-11-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248539, encodeId=2df71248539b7, content=2个审稿人都接收了，4天过去编辑还没给消息。。什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Sep 12 20:23:46 CST 2022, time=2022-09-12, status=1, ipAttribution=)]
    2022-11-27 ms1000001829678046 来自山东省

    你们一般proof后多久见刊的呀？

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1211916, encodeId=4954121191603, content=Enter your thread title<br>这是要填什么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Apr 17 15:16:07 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135109, encodeId=cfe72135109f5, content=偏重的研究方向：外科<br>经验分享：final validation阶段需要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f62574267, createdName=1258d7a0m09暂无昵称, createdTime=Tue May 16 13:58:54 CST 2023, time=2023-05-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116508, encodeId=2e562116508af, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：2022.10.11投稿 2022.11月底接受 版面费交了 proof也提交了。2023.1月底说我文章外审有问题，重新拒绝退回版面费。非常差的一次体验。后来预警期刊出来了被预警了，以后不会考虑这个系列了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/25/b822cea76f86c21288adfae363c6acee.jpg, createdBy=b6602342517, createdName=YYS9508, createdTime=Sun Feb 26 09:58:21 CST 2023, time=2023-02-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2094855, encodeId=4c9b2094855e3, content=投了一篇case，两个审稿人打分都挺高，直接让小修后发表，在编辑那里等了半个月后直接拒稿，说不符合发表要求，请问这是什么意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210429/0b370c04c4bc468c8fc0295b10899aec/93fd51e1588243e988a6774ce1b01133.jpg, createdBy=5dd75468579, createdName=杨豆豆哎, createdTime=Wed Oct 19 23:40:04 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112666, encodeId=f0dc2112666e3, content=偏重的研究方向：外科手术<br>经验分享：我版面费没交，文章也发表了，是什么情况，今年还进了预警名单，在考虑要不要撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ce16588031, createdName=ms3000000392481740, createdTime=Wed Feb 01 23:52:02 CST 2023, time=2023-02-01, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2112308, encodeId=5b5521123087c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：外科<br>经验分享：被预警了啊！！！ https://earlywarning.fenqubiao.com/#/zh-cn/early-warning-journal-list-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Jan 31 01:44:15 CST 2023, time=2023-01-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1237965, encodeId=fca9123e96570, content=偏重的研究方向：胃癌<br>经验分享：很开心，今天刚收到invoive,同意发表，经历了大概5个月，给了一次小修，感觉难度不大，本人做的是本院临床数据库的nomo模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Thu Aug 11 00:37:07 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237840, encodeId=1fdc123e8404f, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿太慢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17db5680759, createdName=ms8000000287670154, createdTime=Wed Aug 10 14:55:45 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102855, encodeId=a67c21028556b, content=你们一般proof后多久见刊的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Sun Nov 27 09:43:37 CST 2022, time=2022-11-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248539, encodeId=2df71248539b7, content=2个审稿人都接收了，4天过去编辑还没给消息。。什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Sep 12 20:23:46 CST 2022, time=2022-09-12, status=1, ipAttribution=)]
    2022-09-12 1254b90bm49(暂无昵称)

    2个审稿人都接收了，4天过去编辑还没给消息。。什么情况

    6

    展开6条回复
共227条页码: 1/23页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map